Skip to content
PubMed This is a summary of 8 peer-reviewed journal articles Updated
Neurology

Symptoms and Clinical Presentation of CNTNAP2-Related DEE

At a Glance

CNTNAP2-related DEE usually begins in early childhood with seizures, often starting in the temporal lobe, alongside developmental delay and severe language difficulties. Children may also have autism-like behaviors, low muscle tone, and balance or walking problems.

CNTNAP2-related developmental and epileptic encephalopathy (DEE) presents a complex set of challenges that typically emerge in early childhood. While every child’s journey is unique, research has identified several “hallmark” symptoms—specifically involving seizures, language, and behavior—that define this condition [1][2]. Understanding these patterns can help you and your medical team anticipate your child’s needs and provide the right support.

Seizure Onset and Types

For most children with this condition, epilepsy begins early in life. Research indicates that seizures typically start within the first two years, with a median onset of approximately 22.5 months in one cohort [1]. However, the range of onset can span from the first few months up to a few years of age [2].

The most common type of seizure in this disorder is the focal seizure, specifically those with temporal-lobe onset [3].

  • Focal Seizures: These seizures start in one specific area of the brain rather than the whole brain at once [3].
  • Temporal-Lobe Semiology: This refers to the specific symptoms seen when the temporal lobe is involved. These can include a “blank stare,” repetitive movements (like lip-smacking or picking at clothes), or sudden changes in awareness. Because staring and lip-smacking can also happen for everyday reasons, they should prompt clinical evaluation rather than parental self-diagnosis [3].
  • Ictal EEG Findings: When doctors record a seizure using an EEG (electroencephalogram), some cohorts report seeing seizures starting independently on both the left and right sides of the brain’s temporal regions [3].

Seizure control varies significantly. While about two-thirds of children in some studies respond well to antiseizure medications, others develop pharmacoresistant epilepsy, meaning the seizures are difficult to control even with multiple drugs [1][3].

Impact on Development and Language

Developmental challenges are a core feature of CNTNAP2-related DEE. These issues often appear before seizures begin, emphasizing that the genetic mutation itself impacts brain development independently of the epilepsy [4].

  • Global Developmental Delay: Most children experience significant delays across all areas, including motor skills, social interaction, and learning [1].
  • Cognitive Disability: The majority of affected individuals have moderate-to-profound intellectual disability [1].
  • Severe Language Impairment: Language is often the area most severely affected. Some children experience language regression, where they lose the few words or communication skills they had previously gained [5][2]. Speech may remain very limited or entirely absent throughout life [1].

Importantly, even if seizures are successfully controlled with medication, developmental and language challenges typically persist, as they are rooted in the underlying CASPR2-deficiency [5]. However, achieving better seizure control can still meaningfully improve a child’s alertness, attention, and capacity to learn [4].

Behavioral and Neuropsychiatric Features

Children with this condition frequently show behavioral symptoms that overlap with other neurodevelopmental disorders.

  • Autism Spectrum Disorder (ASD): High rates of autism-like behaviors, including difficulties with social communication and repetitive behaviors, are well-documented in biallelic cases [1][2].
  • Behavioral Abnormalities: General behavioral challenges, such as hyperactivity or sensory processing issues, are common [2].
  • Sleep and Mood: While less studied in humans than in animal models, many families report disruptions in sleep patterns and challenges with emotional regulation [6].

Motor and Physical Symptoms

The condition also affects how a child moves and physically interacts with their environment.

  • Hypotonia: This is often referred to as “low muscle tone” or feeling “floppy.” It can make it harder for infants to hold their heads up and can delay milestones like sitting and crawling [2].
  • Gait Abnormalities: As children get older, they may have an unsteady or wide-based walk (ataxia). These balance and coordination issues can impact their ability to navigate their surroundings safely and may require physical therapy or supportive devices [2].

Why Names Matter: CDFE vs. PTHLS1

As discussed in earlier sections, you may hear this condition called Cortical Dysplasia–Focal Epilepsy syndrome (CDFE) or Pitt-Hopkins-like syndrome 1 (PTHLS1).

  • CDFE is often used when brain imaging (MRI) shows cortical dysplasia—areas where the brain’s outer layer didn’t form quite right [7].
  • PTHLS1 is often used when the focus is on the profound developmental delays and autism-like features [8].

Regardless of the label used, the underlying cause is the same CNTNAP2 mutation, and the day-to-day management remains focused on treating the seizures and supporting development [1].

Common questions in this guide

At what age do seizures usually start in CNTNAP2-related DEE?
Seizures often begin during the first two years of life, although they can start in infancy or later in early childhood. Focal seizures, especially those beginning in the temporal lobe, are commonly reported.
How might a temporal-lobe seizure appear in my child?
A child may have a blank stare, repetitive movements such as lip-smacking or picking at clothing, or a sudden change in awareness. These behaviors can have other explanations, so seizure concerns should be assessed by a clinician and, when appropriate, with an EEG.
Can seizure control restore language and development?
Better seizure control can improve alertness, attention, and the ability to learn, but developmental and language challenges often persist because they are also linked to the underlying genetic condition. Some children have very limited speech or lose previously acquired words.
What developmental and behavioral changes are common?
Common features include global developmental delay, intellectual disability, severe language impairment, autism-like social or repetitive behaviors, hyperactivity, sensory processing difficulties, sleep disruption, and emotional regulation problems. Some children experience language regression and lose skills they previously gained.
What movement problems can occur, and can therapy help?
Low muscle tone may make an infant seem floppy and delay head control, sitting, or crawling. Later, an unsteady or wide-based walk can occur, and a clinician may recommend physical or occupational therapy or supportive devices.
Are CDFE and PTHLS1 different names for this condition?
They can be labels for different clinical presentations of the same CNTNAP2-related disorder. CDFE often emphasizes cortical dysplasia seen on MRI, while PTHLS1 emphasizes profound developmental delay and autism-like features; both require individualized seizure and developmental support.
Should communication tools such as AAC be introduced early?
Because speech may remain very limited or may regress, caregivers can ask the care team about early communication supports such as augmentative and alternative communication devices. These tools may give a child additional ways to communicate while speech skills are developing or if speech is lost.

Get notified when new evidence is published on CNTNAP2-related developmental and epileptic encephalopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (8)
  1. 1

    Genotype-phenotype correlation in contactin-associated protein-like 2 (CNTNAP-2) developmental disorder.

    D'Onofrio G, Accogli A, Severino M, et al.

    Human genetics 2023; (142(7)):909-925 doi:10.1007/s00439-023-02552-2.

    PMID: 37183190
  2. 2

    Eight further individuals with intellectual disability and epilepsy carrying bi-allelic CNTNAP2 aberrations allow delineation of the mutational and phenotypic spectrum.

    Smogavec M, Cleall A, Hoyer J, et al.

    Journal of medical genetics 2016; (53(12)):820-827 doi:10.1136/jmedgenet-2016-103880.

    PMID: 27439707
  3. 3

    Bilateral temporal lobe dysplasia and seizure onset associated with biallelic CNTNAP2 variants.

    Panza N, Bianchini C, Cetica V, et al.

    Epilepsia open 2024; (9(1)):417-423 doi:10.1002/epi4.12843.

    PMID: 37805811
  4. 4

    Deciphering the concepts behind "Epileptic encephalopathy" and "Developmental and epileptic encephalopathy".

    Scheffer IE, Liao J

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2020; (24()):11-14 doi:10.1016/j.ejpn.2019.12.023.

    PMID: 31926847
  5. 5

    CNTNAP2 in neurodevelopmental disorders: Genetics, excitation/inhibition mechanisms and preclinical evidence.

    Dhungel A, Bora R, Chamidah AN, Menge DM

    Molecular and cellular neurosciences 2026; (139()):104127 doi:10.1016/j.mcn.2026.104127.

    PMID: 42815598
  6. 6

    Dissociating the Effects of Light at Night from Circadian Misalignment in a Neurodevelopmental Disorder Mouse Model Using Ultradian Light-Dark Cycles.

    Villanueva SAMB, Wang HB, Nguyen-Ngo K, et al.

    bioRxiv : the preprint server for biology 2025; doi:10.1101/2025.07.04.663193.

    PMID: 40631310
  7. 7

    Exploring the clinical spectrum of CNTNAP2-related neurodevelopmental disorders: A case series and a literature appraisal.

    Barcia G, Scorrano G, Rio M, et al.

    European journal of medical genetics 2024; (72()):104979 doi:10.1016/j.ejmg.2024.104979.

    PMID: 39423951
  8. 8

    Pitt Hopkins-Like Syndrome 1 with Novel CNTNAP2 Mutation in Siblings.

    Mittal R, Kumar A, Ladda R, et al.

    Child neurology open 2021; (8()):2329048X211055330 doi:10.1177/2329048X211055330.

    PMID: 34778490

This page is for informational purposes only and does not constitute medical advice. Your child’s healthcare team should interpret seizure episodes, developmental changes, EEG findings, and therapy needs.